Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PFIZER   TEVA PHARMA
EQUITY SHARE DATA
    PFIZER
Mar-23
TEVA PHARMA
Dec-13
PFIZER/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs4,6623,479-   
Low Rs3,4073,022-   
Sales per share (Unadj.) Rs530.01,996.4-  
Earnings per share (Unadj.) Rs136.4124.7-  
Cash flow per share (Unadj.) Rs159.4286.1-  
Dividends per share (Unadj.) Rs70.00109.18-  
Avg Dividend yield %1.73.4 51.7%  
Book value per share (Unadj.) Rs701.02,217.6-  
Shares outstanding (eoy) m45.75848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.61.6 467.6%   
Avg P/E ratio x29.626.1 113.5%  
P/CF ratio (eoy) x25.311.4 222.7%  
Price / Book Value ratio x5.81.5 392.7%  
Dividend payout %51.387.5 58.6%   
Avg Mkt Cap Rs m184,5762,756,220 6.7%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m3,3170-   
Avg. sales/employee Rs Th037,667.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,353.1-  
INCOME DATA
Net Sales Rs m24,2481,692,969 1.4%  
Other income Rs m1,0110-   
Total revenues Rs m25,2581,692,969 1.5%   
Gross profit Rs m8,420463,620 1.8%  
Depreciation Rs m1,055136,844 0.8%   
Interest Rs m13533,253 0.4%   
Profit before tax Rs m8,240293,523 2.8%   
Minority Interest Rs m01,333 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,682 -0.0%   
Tax Rs m2,001-3,584 -55.8%   
Profit after tax Rs m6,239105,758 5.9%  
Gross profit margin %34.727.4 126.8%  
Effective tax rate %24.3-1.2 -1,988.8%   
Net profit margin %25.76.2 411.9%  
BALANCE SHEET DATA
Current assets Rs m24,9331,143,425 2.2%   
Current liabilities Rs m6,574997,163 0.7%   
Net working cap to sales %75.78.6 876.4%  
Current ratio x3.81.1 330.8%  
Inventory Days Days9391 102.9%  
Debtors Days Days296 2.4%  
Net fixed assets Rs m13,780552,961 2.5%   
Share capital Rs m4584,167 11.0%   
"Free" reserves Rs m31,6160-   
Net worth Rs m32,0731,880,567 1.7%   
Long term debt Rs m0865,653 0.0%   
Total assets Rs m39,0313,868,976 1.0%  
Interest coverage x62.19.8 632.2%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.60.4 142.0%   
Return on assets %16.33.6 454.5%  
Return on equity %19.55.6 345.9%  
Return on capital %26.14.9 529.5%  
Exports to sales %2.80-   
Imports to sales %00-   
Net fx Rs m6790-   
CASH FLOW
From Operations Rs m3,557269,772 1.3%  
From Investments Rs m-361-95,591 0.4%  
From Financial Activity Rs m-3,458-323,609 1.1%  
Net Cashflow Rs m-262-149,429 0.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare PFIZER With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare PFIZER With: BROOKS LAB  ZOTA HEALTH CARE  SOTAC PHARMACEUTICALS LTD.  AARTI PHARMALABS  ELDER PHARMA  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.